The overexpression of ASPH in several human solid tumors, such as pancreatic ductal adenocarcinoma [17], breast cancer [18], colorectal cancer [19], cholangiocarcinoma [20], and hepatocarcinoma [21], has been observed. This evidence concerns the gene ASPH and pancreatic ductal adenocarcinoma.